-
Previous
A939572 Liposomes
$2,995.00
- Next
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2
$2,995.00
PEGylated liposomes containing PI3Kγ inhibitor Eganelisib (IPI-549). Eganelisib (IPI-549) is a potent and selective PI3Kγ inhibitor (IC50 16 nM) which is reported to exhibit more than 100-fold selectivity over other lipid and protein kinases and potentiate immunotherapy with immune checkpoint inhibitors in mice. IPI-549 is insoluble in aqueous media. This product is a pre-formulated liposomal version of IPI-549 which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
We synthesize custom liposomes like this. To see a full list of our formulation capabilities, click here.
Available Options:
Specifications
Product Data:
Figure 1 (Thumbnail). Solubilization of Eganelisib (IPI-549) by liposomes. Eganelisib is shown under magnification in free or liposomal forms at 2.0 mg/mL. Left: Eganelisib is insoluble in aqueous media. Eganelisib was dissolved in DMSO and diluted in 322 Buffer (292 mM sucrose, 0.5% DPBS) to examine aqueous solubility. Right: Matched concentration of Eganelisib is shown in liposomal form (formulation WNX5.2) in the same bulk solution.
Figure 2. DLS analysis of Eganelisib (IPI-549) Liposomes, Formulation WNX5.2 (batch 93263). The average size and PDI of triplicate measurements are annotated on the representative snapshot from DLS data acquisition screen. The data are representative of a typical batch.
Details
|
|
DLL-0015 |
|
PEGylated liposomes loaded with Eganelisib (IPI-549) |
|
Formulation No. | WNX5.2 |
Concentration Total Lipid | 60 mM |
Concentration Eganelisib | 2.0 mg/mL |
Hydration Solution | 292 mM sucrose, 0.5% DPBS (1X) |
External Solution | 292 mM sucrose, 0.5% DPBS (1X) |
Liposome Avg. Size | 70-120 nm |
Bioactive Compound Details
|
|
Encapsulated Compound | Eganelisib |
Alias(es) | IPI-549 |
CAS No. | 1693758-51-8 |
Target | PI3Kγ |
Signaling Pathway | PI3K |
Custom Orders
We synthesize custom liposomes like this. Contact us today to request a custom formulation.
Quick Links:
Liposome Formulation Development
Additional Information
Additional Information
Liquid, suspension | |
2 °C to 8 °C (do not freeze), protect from light | |
Shelf Life* | At least 1 month |
Applications | |
Background | |
References |
*Product is too new for long-term stability data. This section will be updated regularly as new data becomes available.